Sanai Health Industry : INSIDE INFORMATION - ANNOUNCEMENT REQUEST FOR REVIEW OF THE LISTING COMMITTEE'S DECISION TO SUSPEND TRADING IN THE SHARES OF THE COMPANY

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Sanai Health Industry Group Company Limited

三愛健康產業集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1889)

INSIDE INFORMATION

ANNOUNCEMENT

REQUEST FOR REVIEW OF THE LISTING COMMITTEE'S

DECISION TO SUSPEND TRADING IN THE SHARES

OF THE COMPANY

This announcement is made by Sanai Health Industry Group Company Limited (the "Company") pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Inside Information Provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO").

Reference is also made to the announcements of the Company dated 26 May 2019, 28 May 2019, 4 June 2019 and 9 September 2019 (the "Announcements"). Capitalised terms used herein shall bear the same meanings as defined in the Announcements unless otherwise stated.

After seeking professional advice, on 16 September 2019, the Company submitted a written request to the Listing (Review) Committee of the Stock Exchange for the Decision to be referred to the Listing (Review) Committee of the Stock Exchange for review (the "2nd Review Request") pursuant to Rule 2B.06(2) of the Listing Rules.

The Directors remind the Shareholders and potential investors that the outcome of the 2nd Review Request is uncertain.

Further announcement(s) will be made by the Company as and when appropriate and in accordance with the requirements of the Listing Rules.

- 1 -

Shareholders who have any queries about the implications of the Decision Letter and 2nd Review Request are advised to obtain appropriate professional advice. Shareholders and potential investors are advised to exercise caution when dealing in the securities of the Company.

By order of the Board

Sanai Health Industry Group Company Limited

Chen Chengqing

Chairman

Hong Kong, 16 September 2019

As at the date of this announcement, the Board comprises five executive Directors, namely, Mr. Chen Chengqing (Chairman), Mr. Gao Borui and Mr. Yuan Chaoyang, Professor Zhang Rongqing and Mr. Cheng Hok Kai, Frederick; one non-executive director, namely, Mr. Xiu Yuan; and three independent non-executive Directors, namely, Mr. Wang Zihao, Mr. Tu Fangkui and Mr. Long Jun.

- 2 -